MARAMPON, Francesco
MARAMPON, Francesco
Dipartimento di Medicina clinica, sanità pubblica, scienze della vita e dell'ambiente
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and surviving in prostate cancer models
2015-01-01 Gravina, GIOVANNI LUCA; Mancini, Andrea; Sanita', Patrizia; Vitale, Flora; Marampon, Francesco; Ventura, Luca; Landesman, Yosef; Mccauley, Dilara; Kauffman, Michael; Shacham, Sharon; Festuccia, Claudio
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results
2016-01-01 DE FELICE, Francesca; Musio, Daniela; Gravina, GIOVANNI LUCA; Marampon, Francesco; Tombolini, Vincenzo
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis
2016-01-01 Marampon, Francesco; Gravina, GIOVANNI LUCA; Festuccia, Claudio; Popov, V. M.; Colapietro, E. A.; Sanità, P.; Musio, D.; De Felice, F.; Lenzi, A.; Jannini, E. A.; DI CESARE, Ernesto; Tombolini, V.
Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: A retrospective study by propensity analysis
2016-01-01 Zugaro, Luigi; Di Staso, Mario; Gravina, GIOVANNI LUCA; Bonfili, Pierluigi; Gregori, LORENZO MARIA; Franzese, Pietro; Marampon, Francesco; Tombolini, Vincenzo; DI CESARE, Ernesto; Masciocchi, Carlo
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage
2016-01-01 Marampon, Francesco; Gravina, GIOVANNI LUCA; Ju, X; Vetuschi, Antonella; Sferra, Roberta; Casimiro, M. C; Pompili, Simona; Festuccia, Claudio; Colapietro, Alessandro; Gaudio, E; DI CESARE, Ernesto; Tombolini, V; Pestell, R. G.
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models
2016-01-01 Gravina, GIOVANNI LUCA; Mancini, Andrea; Scarsella, Luca; Colapietro, Alessandro; Jitariuc, Ana; Vitale, Flora; Marampon, Francesco; Ricevuto, Enrico; Festuccia, Claudio
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
2017-01-01 Gravina, GIOVANNI LUCA; Mancini, Andrea; Marampon, Francesco; Colapietro, Alessandro; DELLE MONACHE, Simona; Sferra, Roberta; Vitale, Flora; Richardson, Peter J.; Patient, Lee; Burbidge, Stephen; Festuccia, Claudio
The First Negative Allosteric Modulator for Dopamine D2and D3Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs
2017-01-01 Rossi, Mario; Fasciani, Irene; Marampon, Francesco; Maggio, Roberto; Scarselli, Marco
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
2017-01-01 Megiorni, Francesca; Gravina, Giovanni Luca; Camero, Simona; Ceccarelli, Simona; DEL FATTORE, Andrea; Desiderio, Vincenzo; Papaccio, Federica; Mcdowell, Heather P.; Shukla, Rajeev; Pizzuti, Antonio; Beirinckx, Filip; Pujuguet, Philippe; Saniere, Laurent; Der Aar, Ellen Van; Maggio, Roberto; De Felice, Francesca; Marchese, Cinzia; Dominici, Carlo; Tombolini, Vincenzo; Festuccia, Claudio; Marampon, Francesco
The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study
2017-01-01 Sferra, Roberta; Pompili, Simona; Festuccia, Claudio; Marampon, Francesco; Gravina, GIOVANNI LUCA; Ventura, Luca; DI CESARE, Ernesto; Cicchinelli, Sara; Gaudio, Eugenio; Vetuschi, Antonella
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo
2018-01-01 Ciccarelli, C.; Di Rocco, A.; Gravina, G. L.; Mauro, A.; Festuccia, C.; Del Fattore, A.; Berardinelli, P.; De Felice, F.; Musio, D.; Bouche, M.; Tombolini, V.; Zani, B. M.; Marampon, F.
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma
2018-01-01 Marampon, Francesco; Leoni, Flavio; Mancini, Andrea; Pietrantoni, Ilaria; Codenotti, Silvia; Ferella, Letizia; Megiorni, Francesca; Porro, Giuliana; Galbiati, Elisabetta; Pozzi, Pietro; Mascagni, Paolo; Budillon, Alfredo; Maggio, Roberto; Tombolini, Vincenzo; Fanzani, Alessandro; Gravina, Giovanni Luca; Festuccia, Claudio
Dichlorodiphenyltrichloroethane, an old pesticide with a new mechanism of toxicity
2018-01-01 Pietrantoni, Ilaria; Rossi, Mario; Scarselli, Marco; Fasciani, Irene; Marampon, Francesco; Maggio, Roberto
Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3receptors
2018-01-01 Fasciani, Irene; Pietrantoni, Ilaria; Rossi, Mario; Mannoury la Cour, Clotilde; Aloisi, Gabriella; Marampon, Francesco; Scarselli, Marco; Millan, Mark J; Maggio, Roberto
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
2018-01-01 Festuccia, Claudio; Mancini, Andrea; Colapietro, Alessandro; Gravina, Giovanni Luca; Vitale, Flora; Marampon, Francesco; Delle Monache, Simona; Pompili, Simona; Cristiano, Loredana; Vetuschi, Antonella; Tombolini, Vincenzo; Chen, Yi; Mehrling, Thomas
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6)
2018-01-01 Festuccia, C; Mancini, A; Colapietro, A; Gravina, G L; Vitale, F; Marampon, F; Delle Monache, S; Pompili, S; Cristiano, L; Vetuschi, A; Tombolini, V; Chen, Y; Mehrling, T
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8)
2019-01-01 Marampon, F.; Leoni, F.; Mancini, A.; Pietrantoni, I.; Codenotti, S.; Ferella, L.; Megiorni, F.; Porro, G.; Galbiati, E.; Pozzi, P.; Mascagni, P.; Budillon, A.; Maggio, R.; Tombolini, V.; Fanzani, A.; Gravina, G. L.; Festuccia, C.
The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models
2019-01-01 Gravina, Giovanni Luca; Mancini, Andrea; Colapietro, Alessandro; Delle Monache, Simona; Sferra, Roberta; Pompili, Simona; Vitale, Flora; Martellucci, Stefano; Marampon, Francesco; Mattei, Vincenzo; Biordi, Leda; Sherris, David; Festuccia, Claudio
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis
2019-01-01 Ferella, L.; Limoncin, E.; Vittorini, F.; Chalaszczyk, A.; Sorce, C.; Grimaldi, G.; Franzese, P.; Ruggieri, V.; Varrassi, E.; Di Staso, M.; Gimenez De Lorenzo, R.; Marampon, F.; Tombolini, V.; Masciocchi, C.; Gravina, G. L.
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program
2019-01-01 Felice, F. D. E.; Megiorni, F.; Pietrantonio, I.; Tini, P.; Lessiani, G.; Mastroiacovo, D.; Mattana, P.; Antinozzi, C.; Luigi, L. D. I.; Delle Monache, S.; Angelucci, A.; Festuccia, C.; Fanzani, A.; Maggio, R.; Tombolini, V.; Gravina, G. L.; Marampon, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and surviving in prostate cancer models | 1-gen-2015 | Gravina, GIOVANNI LUCA; Mancini, Andrea; Sanita', Patrizia; Vitale, Flora; Marampon, Francesco; Ventura, Luca; Landesman, Yosef; Mccauley, Dilara; Kauffman, Michael; Shacham, Sharon; Festuccia, Claudio | |
| Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results | 1-gen-2016 | DE FELICE, Francesca; Musio, Daniela; Gravina, GIOVANNI LUCA; Marampon, Francesco; Tombolini, Vincenzo | |
| Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis | 1-gen-2016 | Marampon, Francesco; Gravina, GIOVANNI LUCA; Festuccia, Claudio; Popov, V. M.; Colapietro, E. A.; Sanità, P.; Musio, D.; De Felice, F.; Lenzi, A.; Jannini, E. A.; DI CESARE, Ernesto; Tombolini, V. | |
| Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: A retrospective study by propensity analysis | 1-gen-2016 | Zugaro, Luigi; Di Staso, Mario; Gravina, GIOVANNI LUCA; Bonfili, Pierluigi; Gregori, LORENZO MARIA; Franzese, Pietro; Marampon, Francesco; Tombolini, Vincenzo; DI CESARE, Ernesto; Masciocchi, Carlo | |
| Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage | 1-gen-2016 | Marampon, Francesco; Gravina, GIOVANNI LUCA; Ju, X; Vetuschi, Antonella; Sferra, Roberta; Casimiro, M. C; Pompili, Simona; Festuccia, Claudio; Colapietro, Alessandro; Gaudio, E; DI CESARE, Ernesto; Tombolini, V; Pestell, R. G. | |
| Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models | 1-gen-2016 | Gravina, GIOVANNI LUCA; Mancini, Andrea; Scarsella, Luca; Colapietro, Alessandro; Jitariuc, Ana; Vitale, Flora; Marampon, Francesco; Ricevuto, Enrico; Festuccia, Claudio | |
| The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma | 1-gen-2017 | Gravina, GIOVANNI LUCA; Mancini, Andrea; Marampon, Francesco; Colapietro, Alessandro; DELLE MONACHE, Simona; Sferra, Roberta; Vitale, Flora; Richardson, Peter J.; Patient, Lee; Burbidge, Stephen; Festuccia, Claudio | |
| The First Negative Allosteric Modulator for Dopamine D2and D3Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs | 1-gen-2017 | Rossi, Mario; Fasciani, Irene; Marampon, Francesco; Maggio, Roberto; Scarselli, Marco | |
| Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells | 1-gen-2017 | Megiorni, Francesca; Gravina, Giovanni Luca; Camero, Simona; Ceccarelli, Simona; DEL FATTORE, Andrea; Desiderio, Vincenzo; Papaccio, Federica; Mcdowell, Heather P.; Shukla, Rajeev; Pizzuti, Antonio; Beirinckx, Filip; Pujuguet, Philippe; Saniere, Laurent; Der Aar, Ellen Van; Maggio, Roberto; De Felice, Francesca; Marchese, Cinzia; Dominici, Carlo; Tombolini, Vincenzo; Festuccia, Claudio; Marampon, Francesco | |
| The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study | 1-gen-2017 | Sferra, Roberta; Pompili, Simona; Festuccia, Claudio; Marampon, Francesco; Gravina, GIOVANNI LUCA; Ventura, Luca; DI CESARE, Ernesto; Cicchinelli, Sara; Gaudio, Eugenio; Vetuschi, Antonella | |
| Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo | 1-gen-2018 | Ciccarelli, C.; Di Rocco, A.; Gravina, G. L.; Mauro, A.; Festuccia, C.; Del Fattore, A.; Berardinelli, P.; De Felice, F.; Musio, D.; Bouche, M.; Tombolini, V.; Zani, B. M.; Marampon, F. | |
| Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma | 1-gen-2018 | Marampon, Francesco; Leoni, Flavio; Mancini, Andrea; Pietrantoni, Ilaria; Codenotti, Silvia; Ferella, Letizia; Megiorni, Francesca; Porro, Giuliana; Galbiati, Elisabetta; Pozzi, Pietro; Mascagni, Paolo; Budillon, Alfredo; Maggio, Roberto; Tombolini, Vincenzo; Fanzani, Alessandro; Gravina, Giovanni Luca; Festuccia, Claudio | |
| Dichlorodiphenyltrichloroethane, an old pesticide with a new mechanism of toxicity | 1-gen-2018 | Pietrantoni, Ilaria; Rossi, Mario; Scarselli, Marco; Fasciani, Irene; Marampon, Francesco; Maggio, Roberto | |
| Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3receptors | 1-gen-2018 | Fasciani, Irene; Pietrantoni, Ilaria; Rossi, Mario; Mannoury la Cour, Clotilde; Aloisi, Gabriella; Marampon, Francesco; Scarselli, Marco; Millan, Mark J; Maggio, Roberto | |
| The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma | 1-gen-2018 | Festuccia, Claudio; Mancini, Andrea; Colapietro, Alessandro; Gravina, Giovanni Luca; Vitale, Flora; Marampon, Francesco; Delle Monache, Simona; Pompili, Simona; Cristiano, Loredana; Vetuschi, Antonella; Tombolini, Vincenzo; Chen, Yi; Mehrling, Thomas | |
| Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) | 1-gen-2018 | Festuccia, C; Mancini, A; Colapietro, A; Gravina, G L; Vitale, F; Marampon, F; Delle Monache, S; Pompili, S; Cristiano, L; Vetuschi, A; Tombolini, V; Chen, Y; Mehrling, T | |
| Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) | 1-gen-2019 | Marampon, F.; Leoni, F.; Mancini, A.; Pietrantoni, I.; Codenotti, S.; Ferella, L.; Megiorni, F.; Porro, G.; Galbiati, E.; Pozzi, P.; Mascagni, P.; Budillon, A.; Maggio, R.; Tombolini, V.; Fanzani, A.; Gravina, G. L.; Festuccia, C. | |
| The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models | 1-gen-2019 | Gravina, Giovanni Luca; Mancini, Andrea; Colapietro, Alessandro; Delle Monache, Simona; Sferra, Roberta; Pompili, Simona; Vitale, Flora; Martellucci, Stefano; Marampon, Francesco; Mattei, Vincenzo; Biordi, Leda; Sherris, David; Festuccia, Claudio | |
| Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis | 1-gen-2019 | Ferella, L.; Limoncin, E.; Vittorini, F.; Chalaszczyk, A.; Sorce, C.; Grimaldi, G.; Franzese, P.; Ruggieri, V.; Varrassi, E.; Di Staso, M.; Gimenez De Lorenzo, R.; Marampon, F.; Tombolini, V.; Masciocchi, C.; Gravina, G. L. | |
| Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program | 1-gen-2019 | Felice, F. D. E.; Megiorni, F.; Pietrantonio, I.; Tini, P.; Lessiani, G.; Mastroiacovo, D.; Mattana, P.; Antinozzi, C.; Luigi, L. D. I.; Delle Monache, S.; Angelucci, A.; Festuccia, C.; Fanzani, A.; Maggio, R.; Tombolini, V.; Gravina, G. L.; Marampon, F. |